NYMXF (Nymox Pharmaceutical) Float Percentage Of Total Shares Outstanding: 61.27% (As of Jul. 11, 2026)


What is Nymox Pharmaceutical Float Percentage Of Total Shares Outstanding?

Nymox Pharmaceutical NYMXF Float Percentage Of Total Shares Outstanding is 61.27% as of Jul. 11, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nymox Pharmaceutical's float shares is 57.93 Mil. Nymox Pharmaceutical's total shares outstanding is 94.54 Mil. Nymox Pharmaceutical's float percentage of total shares outstanding is 61.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nymox Pharmaceutical's Insider Ownership is 29.92%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nymox Pharmaceutical's Institutional Ownership is 0.04%.

Nymox Pharmaceutical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Nymox Pharmaceutical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=57.93/94.54
=61.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 61.27% mean?
Nymox Pharmaceutical (NYMXF) has a Float Percentage Of Total Shares Outstanding of 61.27% as of Jul. 11, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Nymox Pharmaceutical and its competitors.
Is Nymox Pharmaceutical's Float Percentage Of Total Shares Outstanding too high?
Nymox Pharmaceutical's current Float Percentage Of Total Shares Outstanding is 61.27%.
How does Nymox Pharmaceutical's Float Percentage Of Total Shares Outstanding compare to LYRA and RNAZ?
Nymox Pharmaceutical's Float Percentage Of Total Shares Outstanding of 61.27% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Nymox Pharmaceutical and its competitors. Nymox Pharmaceutical's current Float Percentage Of Total Shares Outstanding is 61.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nymox Pharmaceutical stock overvalued right now?
Nymox Pharmaceutical (NYMXF) has a current Float Percentage Of Total Shares Outstanding of 61.27%. The current Float Percentage Of Total Shares Outstanding is 61.27%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Nymox Pharmaceutical (NYMXF), the current Float Percentage Of Total Shares Outstanding is 61.27% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nymox Pharmaceutical Business Description

Address Bay & Deveaux Streets, Nassau, BHS
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and low-grade localized prostate cancer. The company also has an extensive patent portfolio covering its investigational drug as well as other therapeutic and diagnostic indications. It also has U.S. and patent rights for the use of statin drugs for the treatment and prevention of Alzheimer's disease. The company operates in one reportable segment, focused on researching and developing products for the aging population.